Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01329536 · ClinicalTrials.gov registry record
The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease
A clinical trial, sponsored by Avera McKennan Hospital & University Health Center.
- Completed
- Registry status
- 50
- Enrollment target
NCT01329536 is a clinical trial that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 50 participants.
The verdict
NCT01329536 has completed, sponsored by Avera McKennan Hospital & University Health Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this clinical research study is to determine if a specific genetic allele is involved with the development of agitation in patients with late-onset Alzheimer's Disease (AD). The study will compare the results of genetic testing between two groups: individuals with late-onset AD who show signs of agitation and individuals with late-onset AD who do not show signs of agitation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01329536
The ClinicalTrials.gov registry entry for NCT01329536 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avera McKennan Hospital & University Health Center, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01329536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01329536 about?
NCT01329536 is a clinical study titled "The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease". The purpose of this clinical research study is to determine if a specific genetic allele is involved with the development of agitation in patients with late-onset Alzheimer's Disease (AD). The study will compare the results of genetic testing between two groups: individuals with late-onset AD who sh...
What is the current status of trial NCT01329536?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2010-12. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT01329536?
This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.